Group One Trading’s Neurotrope, Inc. Common NTRP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,000
Closed -$1K 6796
2020
Q2
$1K Sell
1,000
-3,500
-78% -$4.38K ﹤0.01% 5704
2020
Q1
$4K Sell
4,500
-5,000
-53% -$5.45K ﹤0.01% 4861
2019
Q4
$9K Sell
9,500
-50,800
-84% -$39.6K ﹤0.01% 4641
2019
Q3
$49K Buy
60,300
+60,000
+20,000% +$275K ﹤0.01% 3984
2019
Q2
$2K Buy
+300
New +$2.02K ﹤0.01% 4792
2018
Q2
Sell
-8,000
Closed -$65K 5666
2018
Q1
$65K Sell
8,000
-3,000
-27% -$23.8K ﹤0.01% 3523
2017
Q4
$77K Sell
11,000
-15,300
-58% -$89.1K ﹤0.01% 3508
2017
Q3
$136K Buy
26,300
+3,600
+16% +$18.9K ﹤0.01% 3025
2017
Q2
$213K Buy
+22,700
New +$242K ﹤0.01% 2602

Other funds holding NTRP

Group One Trading's NTRP Position: Q2 2020 in Review

Group One Trading sold out of Neurotrope, Inc. Common (NTRP) in Q2 2020, closing a stake of 9,037 shares — an estimated $11.3K sold.

Group One Trading first reported a position in NTRP in Q2 2017 and held it in 7 quarters. The position peaked at $222K in Q2 2017. 31 funds tracked by Wall St. Rank hold NTRP as of Q2 2020.

  • Group One Trading reported no remaining Neurotrope, Inc. Common position as of Q2 2020 after selling out during the quarter.
  • Group One Trading sold 9,037 Neurotrope, Inc. Common shares in Q2 2020, an estimated $11.3K.
  • Group One Trading first reported a position in Neurotrope, Inc. Common in Q2 2017 and held it in 7 quarters.
  • Group One Trading's Neurotrope, Inc. Common position peaked at $222K in Q2 2017.
  • 31 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q2 2020.

Based on Group One Trading's 13F filing for Q2 2020, filed 13 Aug 2020.